Related by context. All words. (Click for frequent words.) 76 xvi 72 viii 72 xii 72 xiii 72 xiv 71 xvii 70 xviii 66 vii 66 xxii 65 ix 65 xix 65 xxi 65 iv 63 iii 62 xxv 62 xxiii 61 xxvi 60 xxvii 59 xi 57 vi 57 xxiv 56 ii 56 Immtech clinical trials 55 xxviii 53 collect reinsurance recoverables 52 ourability 51 xxxii 51 ability tosuccessfully 51 risksassociated 50 without limitation 49 risks associatedwith 49 Immtech scientists 49 requirements xxii 49 legal proceedings xxi 49 regarding Heska 49 theability 48 DSL.net s 48 Pure Biofuels ability 48 xxxiii 48 xiv licensing 48 governmental approvals 48 economicconditions 48 HANA MAX 47 withrespect 47 affirmative covenants 47 statementsregarding 47 SumTotal Systems filings 47 unanticipated difficulties 47 representations warranties covenants 47 inventory obsolescence 47 successfully integrate 47 notlimited 47 orotherwise 46 otherfactors 46 retrocessional coverage 46 vii viii 46 general economicconditions 46 incurrence 46 substantial indebtedness 46 materially adversely affect 46 rapid technological 46 changesin 46 aresubject 45 unanticipated 45 ADSI reliance 45 i# implanters 45 acquisitions dispositions 45 xxix 45 including withoutlimitation 45 consummating acquisitions 45 PharMerica LTC Transaction 45 thereby negatively impacting 45 vii IBC 45 incur unanticipated 45 orother 45 associated therewith 44 ourproducts 44 refinance indebtedness 44 multiple lease terminations 44 prepayment speeds loan originations 44 limitedto 44 risksand uncertainties 44 causeactual results 44 risks anduncertainties 44 VIOXX Lawsuits 44 party VLSI fabrication 44 anduncertainties 44 manufacture PolyHeme 44 impactof 43 tenant bankruptcies 43 communicate differentiations effectively 43 Unitholder liability 43 OSI Pharmaceuticals filings 43 market fluctuations investee 43 affecting mortality morbidity 43 areforward looking 43 d Represents 43 Thalomid R 43 Textainer expectation 43 xv licensing 43 product introductions 43 affecting Amarin 43 technological obsolescence 43 includingstatements regarding 43 xvi beer 43 HealthGate ability 43 xxxi 43 Crisa acquisition 43 reinsurance recoverables owed 43 NxStage anticipates 43 credit carryforwards 43 Offerors Commercial applies 43 CAUTION ANY ATTEMPT 42 without limitation Terremark 42 contingent guaranties 42 Cerro Negro concession 42 market PolyHeme commercially 42 MTI MTI Micro 42 withoutlimitation 42 affecting O2Micro 42 [013] 42 otherrisks 42 theCompany 42 related thereto 42 unanticipated geological 42 Equinix filings 42 silico predictive discovery 42 dd DISCOUNTS R 42 Projects Initiation 42 -DEAD BODY 42 adversely affect 42 materially adversely affected 42 vii Dynamic 42 SANCTURA SANCTURA XR NEBIDO 42 Second Supplemental Indenture 42 involverisks 42 technological innovations adversely affecting 42 TeamStaff filings 42 amendments thereto 42 Kronos TiO2 42 Lasertel subsidiary 42 obtaining regulatory approvals 42 § #-#-# b [003] 41 filingswith 41 forward lookingstatements 41 productsand services 41 deploy MDCE services 41 expectations anticipations 41 CAUTIONARY STATEMENT Statements 41 Sepracor anticipates 41 Refinancing Transactions 41 eCOST 41 pricing pressures 41 Heska reliance 41 PLAVIX R patent 41 involve risksand uncertainties 41 #.#-# b [001] 41 arenot limited 41 tarmac strandings Hanni 41 results ofoperations 41 JLG acquisition 41 TranSwitch indebtedness 41 Item IA 41 SeraCare competitors 41 #.#-# b [002] 41 adversely affecting Cubist 41 Shire plc Attention Deficit 41 relatedto 41 Risks uncertainties 41 uncertainties 41 risks uncertainties 41 xii trademark 41 marketconditions 41 assorted pigments resins 41 adverse determinations 41 NASD Marketplace Rule 41 unfavorable geologic 41 Cautionary Disclosures 41 lender consents 41 #.# subd [003] 41 goals expectations anticipations 41 d Reflects 41 date xvii Conversion 41 Mago ® 41 CFR #.#b 41 BioSante licensees 41 maydiffer materially 41 Compans 41 involve risks anduncertainties 41 differ materiallyfrom 41 § #.#-# [004] 41 USC § #a [002] 41 Terremark filings 41 indebtedness covenant 41 purchaserâ € ™ 41 vi vii 40 heading RISK FACTORS 40 worsening peripheral neuropathy 40 work stoppages quarantines 40 Atheros Quarterly Report 40 relating 40 b Excludes 40 Form 8K #K 40 REIT xi 40 maycause actual results 40 dispositions 40 uncertaintiesthat 40 regardingthe 40 AXXX 40 TP# CETi 1 40 technology crystalline ingot 40 risks associated therewith 40 prices drydocking 40 capture exosomes 40 vendor unseasonable weather 40 PDI periodic filings 40 leaseback transactions 40 risks associated 40 § #-#-# b [001] 40 xv adverse 40 dispositions financings 40 vii Cubist ability 40 carryforwards 40 fluctuations cyclicality 40 c SIGA 40 Protonix ® 40 EMPOWER pivotal trial 40 SURETY LICENSES c 40 expenses associated therewith 40 VELCADE therapy 40 Metalline anticipated 40 acquisitions divestitures restructurings 40 unitholder liability 40 iii Cubist 40 PGP Acquisition 40 Westell accounting 40 mergers consolidations 40 variable annuity guarantees 40 CompAir acquisition 40 reflect Ronn Motor 40 couldcause actual results 40 intercompany arrangements 40 timing rescheduling 40 PolyHeme successfully 40 ceded reinsurance 40 may diverge numerically 40 OMNI dependence 40 PLIVA acquisition 40 non capitalizable 40 FAFLIC 40 Ascendiant 40 Jupiterimages respective 40 without limitation EMRISE 40 xiv unanticipated 40 ultimate recoverability 40 Questcor intellectual property 40 i #.# subds 40 toreflect 40 andmarket 40 EcaFlo TM 40 borrower depositor 40 successfully commercialize 40 offerings visit www.balqon.com 40 obsolete inventory 40 offuture 40 Merger Transactions 40 subjectto 40 Congoleum undertakes 40 couldcause 40 Intcomex 40 SANCTURA SANCTURA XR VANTAS 40 withinthe meaning 40 P. #a 40 delinquencies defaults 40 wholly owned subsidiary IPCRe 40 asset dispositions 40 differ materially fromthose 40 successfully integrate Legerity 40 BiDil XR drug 40 § #.#-# [007] 39 Form #KSB filed 39 work stoppages slowdowns 39 FierceGovernmentIT tracks 39 xiii trademark 39 Secure Computing periodic 39 especially Copaxone ® 39 acquisitions divestitures joint ventures 39 looking statements.These 39 arebased 39 suchforward looking 39 OPAXIO pixantrone 39 Dimension BST 39 Cautionary Information 39 iii iv 39 DARA intellectual property 39 renegotiation nullification 39 Slightly offsetting 39 depreciation accretion 39 Value Creation Plan 39 acquisitions divestitures 39 permitting timelines 39 c Relates 39 difficulties foreseeing 39 PrivateSecurities Litigation Reform Act 39 GrowthWorks refers 39 customary representations warranties 39 RISKS AND UNCERTAINTIES 39 debt extinguishments 39 Auxilium anticipates 39 CompanyaEUR TM s 39 commercialize ZYFLO CR 39 brine inflows 39 BY AN ENTRANT 39 futureresults 39 ExchangeCommission 39 periodic redeterminations 39 SemGroup LP SemGroup 39 looking statements 39 Bioaccelerate compounds under 39 theSecurities 39 EAHA shall automatically 39 theforward looking 39 retrocessional reinsurance 39 reasonably determinable 39 accounting pronouncements 39 differmaterially 39 Regulation XXX 39 ProPhotonix 39 associatedwith 39 applicable regulatory approvals 39 Unanticipated 39 Lordsburg Mining District 39 cancellations rescheduling 39 Accurel 39 b Represents 39 NetVault TM 39 CHDT SEC Filings 39 collectibility 39 Iusacell Celular 39 EHSK 39 footwear apparel accessories 39 CompX 39 Partnered Brands segment 39 premium jackups 39 nonoccurrence 39 Analysis C.1 Strengths 39 currency fluctuations imprecision 39 early extinguishments 39 Inventory write downs 39 actualresults 39 Esterhazy Saskatchewan potash 39 Zemiva TM Trofex TM 39 VimpelCom disclaims 39 competitively procured pursuant 39 cause actual 39 retail industries repositionings 39 Lenfest ii 39 forward lookinginformation 39 postretirement benefit plans 39 suchstatements 39 Enpath ability 39 constitutes discloseable transaction 39 f h 39 Restated Revolving Credit 39 Black Canyon mica 39 Company noncontributory defined 38 Polo Jeans Company 38 Subparagraph 38 mw http :/ finance.yahoo.com 38 Idenix anticipates 38 concerning Epigenomics AG 38 distinguishing GigaBeam products 38 uncertainties inherent 38 Oxandrin 38 infringement invalidity 38 constituteforward looking 38 Defendants misrepresented 38 xi unanticipated 38 ALICO Holdings 38 CholeraGarde R Peru 38 RR Donnelley periodic filings 38 Form# K 38 forwarda ^ looking 38 EcaFlo ® equipment 38 Candente relies upon 38 #.#-# Equal Opportunity 38 Fampridine SR Acorda Therapeutics 38 Carolinas Unfavorable primarily 38 LDK Solar filings 38 CORLUX CORT # 38 ARLP Partnership 38 ZERUST R 38 These statementsare 38 attribution authenticity provenance 38 differ materially 38 ALL PROPERTIES ARE SOLD 38 MultiCell bases 38 successfully commercialize REOLYSIN 38 party payors 38 AngelCiti expectations 38 Oligator R oligonucleotides iv 38 APTIMA HPV assay 38 Healthvision acquisition 38 impair Lillian Vernon 38 charterhire rates 38 GEROVA underwrites insurance 38 Proposed Financing 38 i# implanter 38 Newtek beliefs 38 Neurokine 38 drydocking 38 Partially offset 38 MGCD# MGCD# [001] 38 Becancour facilities 38 § #.# [004] 38 dimesylate Attention Deficit 38 thereto 38 c Consists 38 andfinancial 38 Repl. 38 Invitel Holdings operates 38 unforeseen occurrences 38 Somaxon ability 38 Publication Classified Ad 38 noticeably thinner stark 38 diminishing quantities 38 x fluctuating beryllium 38 Bioenvision filings 38 w # yQ 38 Terminates Merger Agreement 38 free E Newsletters 38 securityholder approvals 38 DIP Loan 38 abilityto 38 OneBeacon filings 38 § #-#-# [005] 38 deCODE filings 38 CLX Investments 38 EPIXTAR 'S 38 promulgated thereunder 38 Johnell O 38 DIP Facility 38 performance compliances certifications 38 Ferlay J et al 38 sites xix limitations 38 candidate Ramoplanin 38 LOPROX R 38 SANCTURA R 38 prepayment speeds loan 38 party semiconductor foundries 38 Partially offsetting these 38 BioGlue ® 38 B. Neal Auction 38 thispress release 38 Regains NASDAQ 38 Varvarinskoye Project 38 Direct Indirect 38 restrictive covenants 38 indemnification clauses 38 Reports Inducement Grants 38 collaborations Pharmacopeia 38 pricing IMPAX 38 h r 38 affecting IsoTis 38 PVR lessees 38 Airvana anticipates 38 HF Lenfest member 38 str = i 38 Varian Semiconductor dependence 38 SmarTire dependence 38 Verenium dependence 38 TASE EVGN.TA 38 concerning Alexza 38 reflect VIQ Solutions 38 depreciation depletion amortization 38 cause actualresults 38 ecommerce marketplaces 38 requisite stockholder 38 ofsuch 38 Fourth Supplemental Indenture 38 Colo. Sess 38 PVC Additives 38 NJSA #:#-# [004] 38 adversely affect NextEra Energy 38 successfully commercialize Silenor 38 Amyris oversees 38 cadence regulatory approvals 38 ad valorem taxing 38 Adri Badenhorst Schalk Burger 38 Gottschalks Annual Report 38 TeamStaff GS 38 Merged Entity 38 personnel xvii inability 38 Xantic acquisition 38 surety bonding increased 37 LOUIS Oshiomogho Atogwe 37 doubtful accounts receivable 37 e# periodic 37 KNA ULC 37 partially mitigates 37 FSAH 37 Hejia Software 37 Rexahn licensees 37 file INDs 37 anyforward looking 37 bulk amorphous alloys 37 follows Obagi Nu 37 COPL 37 Excess Cash Flow 37 intellectual property litigations 37 Julius Peppers DE 37 - Operating Expenses [001] 37 Repligen filings 37 consents authorizations 37 NFI ULC 37 geographic concentration 37 payer reimbursement 37 Baqoubah north 37 TrueKnowledge Platform TM 37 itsproducts 37 h g 37 ourbusiness 37 PD2i ® algorithm 37 c Reflects 37 intents beliefs 37 DELETE OR EDIT COMMENTS 37 n h r 37 Bo Scaife TE 37 natural disasters epidemics 37 minesites 37 servicemark risks xiii 37 Liftking 37 RPTN common 37 Oxandrin R 37 #.# subd [004] 37 maycause 37 transportation storage terminalling 37 Sets Earnings Release 37 reflect iSIGN Media 37 xxiii numerous 37 risks unanticipated reclamation 37 historicalfacts 37 Web site http:/www.EmergingStockReport.com 37 contingently liable 37 adversely affect Hologic 37 Powerbase Companies 37 InfoSearch filings 37 involve anumber 37 Hengdali facility 37 Somewhat mitigating 37 adversely affect Univest Corporation 37 Somewhat offsetting these 37 heading ITEM 1A 37 - -Billeaudeau 37 Partially offsetting 37 dispositions joint ventures 37 USC § #f 37 Nuance managements 37 looking statements.Such 37 Holophane R 37 excludes depreciation amortization 37 GoSolutions 37 fluctuations 37 valuation allowances 37 looking statementsaEUR describe 37 liabilities slippage 37 reinsurance recoverable 37 looking statementsare 37 plastic photochromic lens 37 SEC Rule #b 37 Sodisco Howden 37 hyperinflationary environments 37 mortality persistency 37 intercompany indebtedness 37 website www.gladiatorstocks.com 37 Market Disruption 37 INACCURACIES 37 Yima project 37 Manufacturer OEM 37 See USSG § #B#.# 37 GenVec filings 37 LAE reserves 37 TranSwitch filings 37 thereunder 37 expropriation nationalization 37 AspenTech periodic reports 37 reflect Medicago 37 SearchHelp communications 37 TRISENOX R 37 futureperformance 37 periodic reports 37 asset monetizations 37 Taleo disclaims any 37 Theseforward looking 37 theseforward looking 37 commercialized Analyte Specific Reagents 37 regulatory approvals 37 CFR § #.# [004] 37 currency fluctuation 37 involve risks 37 currentexpectations 37 MicroTel 37 mergers dispositions 37 restrictive covenants contained 37 concerning Wowjoint 37 reflect Ronn Motors 37 Atheros Annual Report 37 reestimates 37 adversely affect FNB 37 Redishred 37 Proposed Transactions 37 WNS ADS 37 Achillion anticipates 37 ELESTAT intellectual property 37 Company 37 MGCD# MGCD# [002] 37 InnSuites Hotels 37 iv unanticipated 37 Note Copper Equivalent 37 inflationary pressures adversely affecting 37 OTI Annual Report 37 love veronica Mars 37 SUPPRELIN LA DELATESTRYL 37 xxxv 37 todiffer materially 37 natural disasters pandemics 37 regulatory authorizations 37 x Immtech 37 statements arebased 37 reflecting Maximizer Software 37 Disruptions uncertainty 37 commercialize technological innovations 37 asset impairments 37 reduced workforces scarcity 37 CDO financings 37 Inc NASDAQ CISG 37 USC § #u 37 gastrointestinal GVHD include 37 execute supplemental indenture 37 enforce MOSAID 37 research anddevelopment 37 onForm 37 #.#-# Instructions 37 partially mitigated 37 XP# XP# 37 MHG Annual Report 37 supplemental indenture effecting 37 MIGENIX assumes 37 unscheduled outages 37 innovative StarCured R 37 Excluding acquisitions divestitures 37 professionals technological obsolescence 37 currency fluctuations 37 Bioenvision dependence 37 Restated Declaration 37 thereof 37 #.#-# Contract Terms [002] 37 -#,# -#,# -#,# -#,# [003] 37 intellectualproperty 37 revise anyforward looking 37 Absentee bids shall 37 infringed misappropriated invalid 37 economically recoverable coal 37 HealthTronics periodic filings 37 reflect GuestLogix 37 executed supplemental indenture 37 Consists primarily 37 andgeneral 37 expressed orimplied 36 DTR #.#.# b 36 mature physiologically relevant 36 ISX Data.com uses SafeDinar 36 filedwith 36 wv ` 36 NOL utilization 36 RASP Data Security 36 embedded SuperFlash 36 Voxware filings 36 gastrointestinal pancreatic secretory 36 b Reflects 36 PC OEMS 36 Represents 36 Navios Partners filings 36 Securities andExchange Commission 36 risk mitigant 36 Acticoat TM products 36 distinguishing MDCE products 36 PD2i Analyzer ™ 36 looking statementsâ € 36 selective emitter cell 36 DFAR #.#-# 36 Pharmos filings 36 persistency mortality 36 § #-#.# [003] 36 Wikifamilies 36 MOSAID litigation 36 IEVM 36 assimilating acquired 36 SIMOX SOI 36 #,#,# #,#,# -LAS VEGAS MGM Resorts 36 - Gross ProEva DeHart 36 GulfMark filings 36 precision spindles 36 AMPS Risk 36 NYCRR #.# [003] 36 Sale Transaction 36 Gaoan facility 36 AUCTIONEER CONSIGNOR OR 36 principally attributable 36 Sub metering 36 inherent uncertainty 36 applicable Offering Memorandum 36 Omtool periodic reports 36 constitute discloseable transaction 36 mmoore@equicomgroup.com 36 forward lookingstatement 36 AcryMed technologies 36 Subordinate MBS 36 c html plugins 36 SG &A; 36 unconsolidated investees 36 CAUTIONARY STATEMENT Estimates 36 LogicVision disclaims 36 Nortek Holdings 36 VIACOM INC. AND SUBSIDIARIES 36 postretirement benefits 36 ii Immtech ability 36 consiste en 36 resins polymers 36 SOLODYN R 36 OraTest R 36 Alpine Skiing Riding 36 cause actual resultsto 36 Chase Kishner 36 inventories revalued 36 personnel xviii inability 36 Receivable purchasing 36 cranes Fuchs 36 financial guaranty reinsurance 36 incorporate proprietary Microvolt 36 QSGI offsets 36 VIOXX Product 36 h y 36 seasonality 36 iMergent StoresOnline 36 Tucows filings 36 adopting SFAS #R 36 gathering compressing treating 36 GoFish periodic filings 36 Telesat Telesat leverage 36 AvenEx 36 Partial Tender Offer 36 Suchforward looking 36 Shire Attention Deficit 36 Applied Magnesium 36 className nodes nodes.length = 36 KRYSTEXXA TM 36 forwardlooking statements 36 minerals inc 36 undetected errors 36 intangibles impairment 36 Midwest Consent Decree 36 affecting Pennichuck Corporation 36 adversely affect Waste Connections 36 materially differ 36 Discontinued Operations Including 36 products visit www.adm.com 36 Colin Firth portrays 36 qW 36 paul dev da 36 Sucampo Pharmaceuticals anticipates 36 Isis Alnylam 36 indentures governing 36 adversely impact 36 impacting WesBanco 36 andcost 36 Syntroleum Process 36 · Demonstrated 36 uncertainties materialize Shire plc 36 divestitures 36 related Functional Somatic 36 deploy GigaBeam 36 uBid.com Holdings Inc. 36 BlackPearl Announces 36 Legislation Reform Act 36 Act of# 36 offhire 36 c Excludes 36 indemnifications 36 EcaFlo R 36 #.#-# #.#-# #.#-# #.#-# 36 AudioCodes filings 36 covenant defaults 36 ADSI ability 36 Lordsburg mill comprising 36 affect NYMET Holdings 36 excluding drydocking 36 NorthStar Realty 36 ProLogis Declares Dividends 36 shipper ie 36 § #-#-#.# 36 render PolyHeme obsolete 36 Variable annuities involve 36 viii insufficient 36 Consummation 36 Radware Form 36 andother 36 Prelude SkinPrep Systems 36 LIFO inventory reserve 36 visit http:/www.nationwide.com 36 conditional verb tenses 36 VYVANSE TM lisdexamfetamine 36 Statement Statements 36 AtheroNova filings 36 update anyforward looking 36 satellite datacasting market 36 operated bakery cafe 36 NASD Rule 36 Factors Affecting Future 36 c Represents 36 information Thème s 36 AMETEK filings 36 workersa compensation 36 assume NO RESPONSIBILITY 36 FAR #.#-# Contract 36 Senior Secured Term 36 visit www.ethosfr.com 36 andeconomic 36 finical instrument ie 36 AND ALL SALES 36 necessary regulatory approvals 36 cyclical downturns affecting 36 Forward lookingstatements 36 Legal #.# 36 mezzanine financings 36 EFFECT OF FOREIGN CURRENCY 36 Mitsue Pipelines 36 Filtran Microcircuits Inc. 36 ofany 36 Income Tax Regs 36 lo que se 36 IVAX Diagnostics 36 Varian Semiconductor reliance 36 WestFire 36 PepsiCo bottling 36 counterparty creditworthiness 36 cyclicality inherent 36 within themeaning 36 t h r 36 NII Holdings Annual Report 36 pY @ q 36 QSPE 36 Colihues tailings impoundment 36 property catastrophe reinsurance 36 financing leasebacks 36 PROS disclaims any 36 Koor ADSs American 36 definitive documentation 36 UMZ deposit 36 ` rk 36 Increases Bought Deal 36 Barrett NDEx 36 proprietary Capillary Aerosolization Technology 36 tiny pteropod 36 regarding Anviron 36 FastFunds Financial Corporation 36 SEC filings 36 TiO2 selling 36 companiesâ € ™ 36 marginalization appalling 36 Reproduced Record RR 36 El Boleo Project 36 aEUR aEUR aEUR aEUR 36 Oxandrin ® 36 Secured Debentures 36 TFC receivables 36 consolidated VIEs 36 Coalcorp Provides Updated 36 Acorda Therapeutics intellectual property 36 Mario Besta 36 Favrille filings 36 Accounts Receivable Financing 36 unsecured indebtedness 36 While Ambrilia anticipates 35 eTelcharge.com Inc. 35 dd DISCOUNTS ® 35 AN/USM-# 35 andassumptions 35 looking statementswithin 35 BFSR reflects 35 please visit www.middlebrookpharma.com 35 TILC 35 obligations hereunder 35 Note Movie showtimes 35 PolyMedix filings 35 Monovisc 35 Inherent 35 Scheduler Plus 35 GUIDANCE AND 35 exhibits thereto 35 CFR #.# [008] 35 competing steel minimills 35 anticipated drydocking 35 § #a [002] 35 USC § #c 35 capital expenditures 35 objectives expectations anticipations 35 Hycroft Mine 35 i g 35 UniversalPHOLED 35 éviter 35 LocatePLUS Statements 35 activate telomerase 35 NES Clothing 35 REIT Exemption 35 regulations xvii 35 OREO valuation 35 indemnification obligations 35 incorporate CXA 35 connection therewith 35 ARIF II 35 visit www.targanta.com 35 Direct xi Indirect 35 Hemispherx involve 35 Including newbuildings 35 Nasdaq Listing Rule 35 Maimon Mine 35 andour 35 transactions contemplated 35 Safe Harbors created 35 unforeseen 35 LifePoint LifePoint Hospitals 35 SCHIP Extension 35 Fab2 capacity 35 surgery gynecology neurosurgery 35 Company periodic filings 35 PD2i Cardiac Analyzer 35 Completes Previously Announced 35 Atheros disclaims 35 Mediaseed R 35 title taxation sociopolitical 35 iii Immtech ability 35 Kung sila pa rin 35 GlobalData viewpoints cover 35 AND RISK FACTORS 35 Tekmira disclaims any 35 polyphenylsulfone 35 LPM TM 35 meaningof Section #A 35 GreenHunter Energy undertakes 35 website StockPreacher.com 35 website www.FreePennyAlerts.com 35 customers licensees licensors 35 ofnew 35 Looking Statements Except 35 uncollectible accounts receivable 35 BOPET film industry 35 Private Securities LitigationReform Act 35 financialstatements 35 subsidiaries Kindred Brookdale 35 identifiable intangibles 35 servicemark risks xiv 35 Vocus filings 35 andbusiness 35 Radware filings 35 - -Commey 35 pharmacotherapeutics 35 evaluating Questcor 35 provocation incitement 35 User Agreement REVISED #-#-# 35 Panlab 35 hpSCs avoid ethical 35 = strlen 35 TCA § #-#-# [003] 35 Kanis JA 35 CFR #.# [002] 35 sequencing gene expression 35 concerning AudioCodes 35 @ y qW 35 QLT Annual Report 35 Commences Offering 35 Plastic2Oil sites 35 #g# 2 35 HS Orka geothermal 35 itsbusiness 35 § #:# [001] 35 recompetes 35 Lithonia Lighting R 35 novel ZFP TFs 35 innovative StarCured ® 35 Detrex stock 35 TBtu 35 DJO Merger 35 possession DIP 35 minimally dilutive 35 website www.PennyStockAlley.com 35 de novo branching 35 BPE Segment 35 assigned Negative Outlooks